Exact Mass: 403.128

Exact Mass Matches: 403.128

Found 47 metabolites which its exact mass value is equals to given mass value 403.128, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3'-(1-Butylphosphoryl)adenosine

{[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}(butoxy)phosphinic acid

C14H22N5O7P (403.1257)


   

Alpidem

2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

C21H23Cl2N3O (403.1218)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

C20H19F6NO (403.1371)


   
   

Isopentyenyladenine riboside monophoshate

Isopentyenyladenine riboside monophoshate

C14H22N5O7P (403.1257)


   

5-[(Alanylhomoserinyl-beta-aspartyl)oxy]-1,2-dihydro-4-hydroxy-3H-pyrazol-3-one

5-[(Alanylhomoserinyl-beta-aspartyl)oxy]-1,2-dihydro-4-hydroxy-3H-pyrazol-3-one

C14H21N5O9 (403.1339)


   
   

3-(L-alanyl-L-homoserinyl-L-aspartyl-betacarboxy)-4-hydroxy-5-oxopyrazole

3-(L-alanyl-L-homoserinyl-L-aspartyl-betacarboxy)-4-hydroxy-5-oxopyrazole

C14H21N5O9 (403.1339)


   

D,L-malbrancheamide

D,L-malbrancheamide

C21H23Cl2N3O (403.1218)


   

3e^?(1-Butylphosphoryl)adenosine

3e^?(1-Butylphosphoryl)adenosine

C14H22N5O7P (403.1257)


   

4-(4-Hydroxyphenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-one

4-(4-Hydroxyphenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-one

C26H17N3O2 (403.1321)


   

(6-BENZHYDRYLOXYCARBONYLAMINO-PURIN-9-YL)-ACETIC ACID

(6-BENZHYDRYLOXYCARBONYLAMINO-PURIN-9-YL)-ACETIC ACID

C21H17N5O4 (403.128)


   

n-(s-benzyl-l-cysteinyl)-2-aminoacridone

n-(s-benzyl-l-cysteinyl)-2-aminoacridone

C23H21N3O2S (403.1354)


   

SCH-23390 maleate

SCH-23390 maleate

C21H22ClNO5 (403.1186)


   
   

tributyl-(4,5-dimethyl-1,3-thiazol-2-yl)stannane

tributyl-(4,5-dimethyl-1,3-thiazol-2-yl)stannane

C17H33NSSn (403.1356)


   

Mono-POC Tenofovir

Mono-POC Tenofovir

C14H22N5O7P (403.1257)


   

N-[3-[(3R)-5-Amino-3-(difluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl-2-pyridinecarboxamide

N-[3-[(3R)-5-Amino-3-(difluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl-2-pyridinecarboxamide

C19H16F3N5O2 (403.1256)


   

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

C20H19F6NO (403.1371)


D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists

   

2-[[3-cyano-4-(2-furanyl)-5,6,7,8-tetrahydroquinolin-2-yl]thio]-N-(2-methylphenyl)acetamide

2-[[3-cyano-4-(2-furanyl)-5,6,7,8-tetrahydroquinolin-2-yl]thio]-N-(2-methylphenyl)acetamide

C23H21N3O2S (403.1354)


   

alpidem

alpidem

C21H23Cl2N3O (403.1218)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine

C20H19F6NO (403.1371)


   

D-4-hydroxyphenylglycine-L-seryl-L 4-hydroxyphenylglycine

D-4-hydroxyphenylglycine-L-seryl-L 4-hydroxyphenylglycine

C19H21N3O7 (403.1379)


   

D-pHPG-L-Ser-L-pHPG

D-pHPG-L-Ser-L-pHPG

C19H21N3O7 (403.1379)


   
   

2-methyl-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

2-methyl-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

C19H21N3O5S (403.1202)


   

(E)-N-[3-(diethylsulfamoyl)phenyl]-3-(3-nitrophenyl)acrylamide

(E)-N-[3-(diethylsulfamoyl)phenyl]-3-(3-nitrophenyl)acrylamide

C19H21N3O5S (403.1202)


   

N-[[1-[(3-fluorophenyl)methyl]-3-indolyl]methylideneamino]-3,5-dihydroxybenzamide

N-[[1-[(3-fluorophenyl)methyl]-3-indolyl]methylideneamino]-3,5-dihydroxybenzamide

C23H18FN3O3 (403.1332)


   

4a-dehydroxycrinamabine Trifluoroacetic acid

4a-dehydroxycrinamabine Trifluoroacetic acid

C18H20F3NO6 (403.1243)


A natural product found in Crinum asiaticum var. sinicum.

   

3-Nitro-4-[2-[1-(phenylmethyl)-4-piperidinylidene]hydrazinyl]benzenesulfonamide

3-Nitro-4-[2-[1-(phenylmethyl)-4-piperidinylidene]hydrazinyl]benzenesulfonamide

C18H21N5O4S (403.1314)


   

Secoxyloganin anion

Secoxyloganin anion

C17H23O11- (403.124)


   

N-[(E)-(3,4-dihydroxyphenyl)methylideneamino]-3-piperidin-1-ylsulfonylbenzamide

N-[(E)-(3,4-dihydroxyphenyl)methylideneamino]-3-piperidin-1-ylsulfonylbenzamide

C19H21N3O5S (403.1202)


   

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-(2,4-dimethoxyphenyl)prop-2-enoate

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-(2,4-dimethoxyphenyl)prop-2-enoate

C19H21N3O7 (403.1379)


   

4,5-Dihydrooxazol-5-one, 4-[4-benzyloxy-2-fluoro-5-methoxybenzylidene]-

4,5-Dihydrooxazol-5-one, 4-[4-benzyloxy-2-fluoro-5-methoxybenzylidene]-

C24H18FNO4 (403.122)


   

secoxyloganin(1-)

secoxyloganin(1-)

C17H23O11 (403.124)


A dicarboxylic acid monoester(1-) that is the conjugate base of secoxyloganin, resulting from the deprotonation of the carboxy group. Major microspecies at pH 7.3.

   

AK-1

AK-1

C19H21N3O5S (403.1202)


AK-1 is a potent, specific and cell-permeable SIRT2 inhibitor, with an IC50 of 12.5 μM.

   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}-4-[(4,5-dihydroxy-1h-pyrazol-3-yl)oxy]-4-oxobutanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}-4-[(4,5-dihydroxy-1h-pyrazol-3-yl)oxy]-4-oxobutanoic acid

C14H21N5O9 (403.1339)


   

(3s,5s,6r,7r,8s)-13-[(z)-(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-11-(pyridin-2-yl)-2,4,9-trioxa-12-azatricyclo[8.4.0.0³,⁸]tetradeca-1(14),10,12-trien-7-ol

(3s,5s,6r,7r,8s)-13-[(z)-(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-11-(pyridin-2-yl)-2,4,9-trioxa-12-azatricyclo[8.4.0.0³,⁸]tetradeca-1(14),10,12-trien-7-ol

C19H21N3O7 (403.1379)


   

(1s,13s,15s)-6,7-dichloro-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-6,7-dichloro-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H23Cl2N3O (403.1218)


   

[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(butoxy)phosphinic acid

[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(butoxy)phosphinic acid

C14H22N5O7P (403.1257)


   

[(2s,3r,4s,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(butoxy)phosphinic acid

[(2s,3r,4s,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(butoxy)phosphinic acid

C14H22N5O7P (403.1257)


   

[(2r,3r,4s,5r)-3,4-dihydroxy-5-[(4r,5s)-6-[(3-methylbut-2-en-1-yl)imino]-4,5-dihydro-3h-purin-9-yl]oxolan-2-yl]oxyphosphonic acid

[(2r,3r,4s,5r)-3,4-dihydroxy-5-[(4r,5s)-6-[(3-methylbut-2-en-1-yl)imino]-4,5-dihydro-3h-purin-9-yl]oxolan-2-yl]oxyphosphonic acid

C14H22N5O7P (403.1257)


   

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)-4-[(4,5-dihydroxy-1h-pyrazol-3-yl)oxy]-4-oxobutanoic acid

2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)-4-[(4,5-dihydroxy-1h-pyrazol-3-yl)oxy]-4-oxobutanoic acid

C14H21N5O9 (403.1339)


   

12-[(z)-(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-14-(pyridin-2-yl)-2,4,9-trioxa-13-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-trien-7-ol

12-[(z)-(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-14-(pyridin-2-yl)-2,4,9-trioxa-13-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-trien-7-ol

C19H21N3O7 (403.1379)


   

6,7-dichloro-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

6,7-dichloro-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H23Cl2N3O (403.1218)


   

13-[(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-11-(pyridin-2-yl)-2,4,9-trioxa-12-azatricyclo[8.4.0.0³,⁸]tetradeca-1(14),10,12-trien-7-ol

13-[(hydroxyimino)methyl]-6,8-dimethoxy-5-methyl-11-(pyridin-2-yl)-2,4,9-trioxa-12-azatricyclo[8.4.0.0³,⁸]tetradeca-1(14),10,12-trien-7-ol

C19H21N3O7 (403.1379)


   

(2e)-2-methyl-n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}but-2-enimidic acid

(2e)-2-methyl-n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}but-2-enimidic acid

C23H21N3O2S (403.1354)